Role of thrombin in angiogenesis and tumor progression

Seminars in Thrombosis and Hemostasis

Volumn 30, Issue 1, 2004, Pages 63-69

  Tsopanoglou, Nikos E ^a   Maragoudakis, Michael E ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiogenesis; Integrin; Thrombin; Tumor; VEGF

Indexed keywords

GELATINASE B; INTEGRIN; MEMBRANE PROTEIN; MESSENGER RNA; THROMBIN; THROMBIN RECEPTOR; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

ANGIOGENESIS; BASEMENT MEMBRANE; BLOOD CLOTTING; CANCER; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN; HISTOPATHOLOGY; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; TUMOR GROWTH;

ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, THROMBIN; THROMBIN;

EID: 1842607575     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822971     Document Type: Review

References (45)

1. Dano K, Andreasen PA, Grondahl-Hansen J, et al. Plasminogen activators, tissue degradation, and cancer [review]. Adv Cancer Res 1985;44:139-266
2. Nash GF, Walsh DC, Kakkar AK. The role of the coagulation system in tumor angiogenesis. Lancet Oncol 2001;2:608-613
3. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983;62:14-31
4. Del Rosso M, Fibbi G, Pucci M, et al. Multiple pathways of cell invasion are regulated by multiple families of serine proteases. Clin Exp Metastasis 2002;19:193-207
5. Martin DMA, Boys CWG, Ruf W. Tissue factor: molecular recognition and cofactor function. FASEB J 1995;9:852-859
6. Hillen HF. Thrombosis in cancer patients. Ann Oncol 2000;11:273-276
7. Tsopanoglou NE, Pipili-Synetos E, Maragoudakis ME. Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am J Physiol 1993;264:C1302-C1307
8. Folkman J. Tumour angiogenesis. Adv Cancer Res 1985;43:175-203
9. Wojtukiewicz MZ, Tang DG, Benjosef E, et al. Solid tumor cells express functional tethered ligand thrombin receptor. Cancer Res 1995;55:698-704
10. Even-Ram S, Uziely B, Cohen P, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998;4:909-914
11. Zacharski LR, Memoli VA, Morain WD, et al. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 1995;73:793-797
12. Mohle R, Green D, Moore MA, et al. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997;94:663-669
13. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by upregulation of its receptors. J Biol Chem 1999;274:23969-23976
14. Klepfish B, Greco MA, Karpatkin S. Thrombin stimulates melanoma tumor cell binding to endothelial cells and subendothelial matrix. Int J Cancer 1993;53:978-982
15. Wojtukiewicz MZ, Tang DG, Ciarelli JJ, et al. Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993;54:793-806
16. Nierodzik ML, Klepfish B, Karpatkin S. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willenbrand factor on tumor adhesion in vitro and metastasis in vivo. Thromb Haemost 1995;74:282-290
17. Dardik R, Savion N, Kaufman Y, et al. Thrombin promotes platelets-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoprotein P-selectin and GPIIb-IIIa. Br J Cancer 1998;77:2069-2075
18. Haralambopoulos GC, Grant DS, Klienman HK, Maragoudakis ME. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997;273:C239-C242
19. Dimitropoulou C, Malkush W, Fait E, Maragoudakis ME, Konerding MA. The vascular architecture of the chick chorioallontoic membrane: sequential quantitative evaluation using corrosion casting. Angiogenesis 1998;2:255-263
20. Maragoudakis ME, Tsopanoglou NE, Sakkoula E, Pipili-Synetos E. On the mechanism of promotion of angiogenesis by thrombin [abstract]. FASEB J 1995;9:A587
21. Herbert JM, Dupuy E, Laplace MC, et al. Thrombin induces endothelial cell growth via both proteolytic and non-proteolytic pathways. Biochem J 1994;303:227-231
22. McNamara CA, Sarembock IJ, Gimple LW, et al. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 1993;91:94-98
23. Macfarlane SR, Seatter MJ, Kanke T, et al. Proteinase-activated receptors. Pharmacol Rev 2001;53:245-282
24. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis: inhibition of attachment of endothelial cells on basement membrane components. Angiogenesis 1998;1:192-200
25. Maragoudakis ME, Kraniti N, Giannopoulou E, et al. Modulation of angiogenesis and progelatinase A by thrombin receptor mimetic and antagonists. Endothelium 2001;8:195-205
26. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31
27. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4-25
28. Eliceiri BP, Cheresh DA. Adhesion events in angiogenesis. Curr Opin Cell Biol 2001;13:563-568
29. v gene expression in human melanoma tumorigenicity. J Clin Invest 1992;89:2018-2022
30. Enenstein J, Kramer RH. Confocal microscopic analysis of integrin expression on the microvasculature and its sprouts in the neonatal foreskin. J Invest Dermatol 1994;103:381-386
31. 3 for angiogenesis. Science 1994;264:569-571
32. Bader BL, Rayburn H, Crowley D, Hynes RO. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins. Cell 1998;95:507-519
33. 5 integrin receptor antagonist. Cancer Res 2001;61:2232-2238
34. 3 antagonist. J Clin Invest 1999;103:47-54
35. 3 integrin. Am J Physiol 2002;283:C1501-C1510
36. Conforti GC, Dominguez-Jimenez B, Zanetti MA, et al. Human endothelial cells express integrin receptors on the luminal aspect of their membrane. Blood 1992;80:437-446
37. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697-715
38. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285:1028-1032
39. Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a non-catalytic metalloproteinase fragment with integrin binding activity. Cell 1998;92:391-400
40. Zucker S, Conner C, Massimo B, et al. Thrombin induces the activation of progelatinase A in vascular endothelial cells. J Biol Chem 1995;270:23730-23738
41. Johnsen M, Lund LR, Romer J, Amholt K, Dano K. Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 1998;10:667-671
42. Zucker S, Mirza H, Conner CE, et al. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Int J Cancer 1998;75:780-786
43. Nierodzik ML, Kajumo F, Karpatkin S. Effects of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and tumor metastasis in vivo. Cancer Res 1992;52:3267-3272
44. 5 integrin. J Biol Chem 2001;276:10952-10962
45. Bar-Shavit R, Gridley G, Vlodavsky I. Binding of thrombin to subendothelial extracellular matrix: protection and expression of functional properties. J Clin Invest 1989;84:1096-1104